Health Care Equipment & Services

Global Health (GLH)

Stock Code

GLH

Stock Exchange

Australian Securities Exchange

Global Health (GLH) specialises in software products for the healthcare industry. GLH’s health solutions business (70% earnings) is marketed under the ‘Global Health’ banner. Working Systems Solutions specialises in e-health, e-business, e-learning and application integration. Its products include Locum 3 for patient management, MasterCare, a browser-based data repository providing clinical information on patients, and e-PAS, a financial, patient, and practice management application.

Fermiscan Holdings (FER)

Stock Code

FER

Stock Exchange

Australian Securities Exchange

Fermiscan Holdings (FER) is the owner of a patented diagnostic technique entitled "Using Hair to Screen for Breast Cancer". The focus of the company is on the development of the technology called The Fermiscan Test, which discovers a technique of using X-ray diffraction of hair to investigate early potential detection for breast cancer. FER is also exploring other diagnostic technologies with the aim of providing low-cost diagnostics for a range of diseases.

Ellex Medical Lasers (ELX)

Stock Code

ELX

Stock Exchange

Australian Securities Exchange

Ellex Medical Lasers (ELX) is involved in the design and manufacture of ophthalmic lasers. ELX manufactures products for Alcon Surgical and Lumenis Inc, as well as distributes under its own brand Laserex. ELX primarily manufactures photodisruptor lasers for the treatment of secondary cataracts and photocoagulator lasers for treating various retinal diseases. ELX was first listed on the ASX as Gemstone Corporation of Australia in 1994. Ellex was founded by Victor Previn as a private company in the late 1980s. In 1988, it introduced the YAG Photocoagulator.

Eastland Medical Systems (EMS)

Stock Code

EMS

Stock Exchange

Australian Securities Exchange

Eastland Medical Systems (EMS) is involved in the development and manufacture of injection, infusion and blood-drawing devices. EMS's products are specifically designed to reduce the risk of needlestick injuries to healthcare workers. Core products include clip on converters, which convert conventional syringes into retractable needles; AutoInjecta, a fillable device for self-administration of drugs; and Safe Line Winged Infusion Set, a flexible IV line that reduces the risk of a needle stick injury.

Isoft Group (ISF)

Stock Code

ISF

Stock Exchange

Australian Securities Exchange

Isoft Group (ISF) supplies software and IT solutions to healthcare providers such as hospitals, clinics, pharmacists, aged care facilities and GPs. ISF's clients range from private healthcare providers such as Healthscope to public sector bodies such as defence forces and health authorities. The company earns revenue from the initial sale of its products, followed by ongoing maintenance, support and licence revenues. iSOFT Group Limited’s products support both private and public sector healthcare provider organizations. On April 24, 2009, the Company acquired Hatrix Pty Limited.

Cyclopharm (CYC)

Stock Code

CYC

Stock Exchange

Australian Securities Exchange

Cyclopharm Limited (CYC) is engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. CYC was listed on ASX on 18 January, 2007. The Company operates in two segments: Technegas and Molecular Imaging. The Technegas segment is a supplier of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The Molecular Imaging segment focuses to produce radiopharmaceuticals to be used by physicians in the detection of cancer, neurological disorders and cardiac disease.

Cordlife (CBB)

Stock Code

CCB

Stock Exchange

Australian Securities Exchange

Cordlife (CBB) core business is in adult stem cell therapeutics and cell-based products and services. Each of the group operating businesses is currently revenue generating. The company owns a portfolio of patented stem cell expansion technology for supporting cellular transplantations, as well as T-cell production technology for restoring the immune system. These technologies will enter clinical trials in 2006 and will evolve to clinical therapeutic products.

Compumedics (CMP)

Stock Code

CMP

Stock Exchange

Australian Securities Exchange

Compumedics (CMP) is a leader in developing and manufacturing diagnostic technology for sleep and associated disorders. CMP was listed on ASX on 21 December, 2000. Its technology focuses on the fast growing sleep medicine market though it is increasingly focusing on the associated fields of neurodiagnostics and brain research. By defining life's signals, CMP's technology turns vast amounts of data into valuable information that leads to more accurate diagnosis and consequently more effective therapy for some of the most serious health conditions.

Clover Corporation (CLV)

Stock Code

CLV

Stock Exchange

Australian Securities Exchange

Clover Corporation Ltd (CLV) develops and markets products from tuna fish oil and other natural oils, for use in the food, pharmaceutical and farming industries. CLV has developed a high grade DHA (Omega-3 fatty acid) for use in children's formula and bread. Hi-DHA is a refined form of tuna fish oil, devoid of smell or taste. The company has also developed a technology to supply Hi-DHA in a dry powder form. CLV is also developing Prosperm a process aimed at incorporating Hi-DHA into animal feed.

CathRx (CXD)

Stock Code

CXD

Stock Exchange

Australian Securities Exchange

CathRx (CXD) is an Australian medical devices company, initially focusing on the development and commercialisation of a range of cardiac catheters for use in the diagnosis and treatment of electrical problems of the heart known as cardiac arrhythmias. The Company is listed on the Australian Securities Exchange where it is traded under the symbol CXD. It's head office, laboratory and manufacturing facilities are based at Homebush Bay in Sydney. The Company prides itself on innovative design and technology to provide catheters with significant advantages for the cardiac clinicians and patients.

Syndicate content

Download our FREE App


Signup for Free
Don't miss out on your free share trading articles.


Free Risk Money Management Calculator for those who sign up!